News

Thumbnail

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

Siemens Healthineers invests $30M into new radiopharma facility

The new site will have up to eight times the manufacturing capacity of any other radiopharmaceutical facility. 

Thumbnail

A special report is raising new concerns about a hospital’s lackluster response to a radiologist's concerns of abuse happening in the organization's NICU.

Heart cardiologists doctors surgery

Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.

The Boston Scientific BodyGuardian Remote Monitoring System uses AI to help detect and monitor cardiac arrhythmias in ambulatory patients.

Cardiology remains the No. 2 healthcare specialty for AI approvals, trailing only radiology. 

Midwest Radiology

Midwest Radiology Director of Recruiting Laurent Grignon, MD, recently spoke with Radiology Business about the successes, divulging some of his strategies. 

AIRS Medical

Founded in 2018, AIRS provides deep-learning solutions including its flagship SwiftMR, which it says reduces scan times while boosting image quality. 

signature

The largest Medicaid-specialized managed care organization in the U.S. is offering buyout packages to most of its 60,000 or so staff workers.

CVS Health announces $10.6B acquisition of Oak Street Health

The pharmacy chain also agreed to perform an annual audit of billed drug prices to ensure it does not run afoul of the state’s “Most Favored Nation” policy. 

Thumbnail

New data out of ESC Congress 2025 suggest care teams can take a more minimalist approach during a majority of TAVR cases and only treat patients with local anesthesia. In some cases, however, sedation will still be necessary. 

the words "FDA recall" on a board

The Class 2 recall pertains to the system's built-in shielding and collimation accessories. 

Abbott's Navitor TAVR valve

Abbott's TAVR valve now has CE mark approval for treating low-, intermediate- and high-risk patients who present with symptomatic severe aortic stenosis. The news comes as new data on the valve's safety and effectiveness were just published in JACC: Cardiovascular Interventions.

Around the web

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

The new site will have up to eight times the manufacturing capacity of any other radiopharmaceutical facility. 

A special report is raising new concerns about a hospital’s lackluster response to a radiologist's concerns of abuse happening in the organization's NICU.